Skip to main content

Table 1 Distribution of ER and HER2 status

From: New network topology approaches reveal differential correlation patterns in breast cancer

Microarray cohort

Californian population[36]

Total

1317

(100%)

100%

ER+

1035

(78.6%)

79.4%

ER-

282

(21.4%)

20.6%

HER2+

208

(15.8%)

21.7%

HER2-

1109

(84.2%)

78.3%

ER+/HER2+

120

(9.1%)

14.6%

ER+/HER2-

915

(69.5%)

64.8%

ER-/HER2+

88

(6.7%)

7.1%

ER-/HER2-

194

(14.7%)

13.5%

  1. Distribution of ER and HER2 status in the microarray cohort and in a large Californian population of 67698 breast cancer patients.